Data Management System Integrates Complex Image Data
By LabMedica International staff writers Posted on 03 Jul 2017 |

Image: The web-based Xplore system will allow for enhanced sharing of pathology and tissue images (Photo courtesy of Philips Healthcare).
A web-based data management system that enables researchers to integrate data from multiple sources including digital pathology and tissue imaging and share information over the Internet is now available.
Royal Philips (Amsterdam, the Netherlands) has launched its Xplore v4.0 comprehensive web-based image and big data management system. Xplore provides a central hub to create, interrogate, share, and manage archives both for individual and collaborative studies. The user can define study hierarchy, datasets, and fields, and import whole slide or TMA (Tissue Micro Array) images.
TMA is an Xplore-related module designed to speed up research studies, which require manual scores of TMA cores. This powerful tool allows manual scoring of TMAs online, which facilitates the evaluation of new tissue biomarkers in TMAs quickly and easily. Using TMA scoring templates, map templates, and an automated de-arrayer, this module ensures that TMA cores will be rapidly segmented, identified, and sent out for scoring. With a single screen/interface for viewing and scoring, management of TMAs is greatly simplified for the pathologist.
Version 4.0 of Xplore comprises a major upgrade for both pharmaceutical and academic researchers, as it provides enhanced search capabilities, barcode support, data visualization tools, and third party image analysis vendor integration.
“Delivering on the promise of personalized medicine means that multiple data sources need to be integrated and analyzed,” said Russ Granzow, general manager of digital pathology solutions at Royal Philips. “Computational pathology research tools will be essential to move forward in our increasingly complex medical and research environment.”
Xplore v4.0 will be available in July 2017. Customers have the option to purchase the basic package or enhance it with custom additions such as the dedicated TMA module.
Royal Philips (Amsterdam, the Netherlands) has launched its Xplore v4.0 comprehensive web-based image and big data management system. Xplore provides a central hub to create, interrogate, share, and manage archives both for individual and collaborative studies. The user can define study hierarchy, datasets, and fields, and import whole slide or TMA (Tissue Micro Array) images.
TMA is an Xplore-related module designed to speed up research studies, which require manual scores of TMA cores. This powerful tool allows manual scoring of TMAs online, which facilitates the evaluation of new tissue biomarkers in TMAs quickly and easily. Using TMA scoring templates, map templates, and an automated de-arrayer, this module ensures that TMA cores will be rapidly segmented, identified, and sent out for scoring. With a single screen/interface for viewing and scoring, management of TMAs is greatly simplified for the pathologist.
Version 4.0 of Xplore comprises a major upgrade for both pharmaceutical and academic researchers, as it provides enhanced search capabilities, barcode support, data visualization tools, and third party image analysis vendor integration.
“Delivering on the promise of personalized medicine means that multiple data sources need to be integrated and analyzed,” said Russ Granzow, general manager of digital pathology solutions at Royal Philips. “Computational pathology research tools will be essential to move forward in our increasingly complex medical and research environment.”
Xplore v4.0 will be available in July 2017. Customers have the option to purchase the basic package or enhance it with custom additions such as the dedicated TMA module.
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreMolecular Diagnostics
view channel
POC Diagnostic Platform Combines Immunoassay and Molecular Testing
An innovative diagnostic platform offers superior sensitivity across all sample types, including blood, compared to existing rapid tests, while maintaining a low-cost, user-friendly design.... Read more
Single Blood Test Could Detect Different Types of Cancer at Early Stages
Currently, reliable screening for only a few types of cancer is available, such as those affecting the breast, bowel, cervix (neck of the womb), and lung for individuals at high risk. While these screenings... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Blood Test Detects Up to Five Infectious Diseases at POC
Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app.... Read more
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreIndustry
view channel
Qiagen Acquires NGS Analysis Software Company Genoox
QIAGEN (Venlo, the Netherlands) has signed a definitive agreement to acquire Genoox (Tel Aviv, Israel), a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and... Read more
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more